Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-02-22 @ 7:22 PM
Study NCT ID:
NCT01779505
Status:
COMPLETED
Last Update Posted:
2014-01-08
First Post:
2013-01-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GS-4774 (GI-13020) at Various Dose Levels and Regimens in Healthy Adults
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01
Start Date Type:
None
Primary Completion Date:
2013-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-24
First Submit QC Date:
None
Study First Post Date:
2013-01-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-06
Last Update Post Date:
2014-01-08
Last Update Post Date Type:
ESTIMATED